Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Control Release ; 226: 15-20, 2016 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-26849917

RESUMO

Herein, we challenged the isolated lung (IL) technique to discriminate the performance of lung-delivered polymeric microparticles (MPs) having distinct drug release rates. For this purpose, sildenafil-loaded poly(lactide-co-glycolide) MPs were administered to the airspace of an IL model and the drug absorption profile was monitored. MPs (particle size of ~5µm) composed of PLGA of lower molecular weight (and glass transition temperature) manifested in the most rapid in vitro drug release (half-times ranging from <15 to ~200min). Moreover, microencapsulation resulted in a delayed sildenafil transfer over the air/perfusate barrier (half-times ranging from <5 to ~230min), where the actual ex vivo absorption profile depended on the release behavior of the utilized formulation. Finally, the obtained in vitro and ex vivo results were tested for level C, B and A correlations. The plotted data showed good agreement (R(2)>0.96) and the slopes of the resulting lines of regression (i.e., 0.80-0.85) indicated a slightly elevated in vitro drug release behavior. Overall, the IL model was able to differentiate between distinct microparticulate formulations and is, therefore, a valuable technique for early testing of potential inhalable controlled release medications.


Assuntos
Preparações de Ação Retardada/química , Pulmão/metabolismo , Poliglactina 910/química , Citrato de Sildenafila/administração & dosagem , Vasodilatadores/administração & dosagem , Animais , Portadores de Fármacos/química , Composição de Medicamentos , Liberação Controlada de Fármacos , Tamanho da Partícula , Coelhos , Citrato de Sildenafila/farmacocinética , Temperatura de Transição , Vasodilatadores/farmacocinética
2.
J Pharm Pharmacol ; 67(10): 1349-54, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25920623

RESUMO

OBJECTIVES: This study investigated the controlled drug release potential of formulations revealing temperature-induced sol-gel transition following administration to the respiratory tract. METHODS: Diverse sildenafil-containing aqueous poloxamer 407 preparations were evaluated for critical gelation temperature and rheological properties. The in-vitro drug release profiles of the in-situ forming formulations were studied in a Franz type cell, while the drug absorption characteristics were determined in an isolated lung model. Furthermore, the weight gain of isolated lungs was monitored and the bronchoalveolar lavage fluid was analysed for the total protein content. KEY FINDINGS: Poloxamer 407 solutions with concentrations of >12 wt.% revealed gelation upon temperature increase (>20°C). Compared with free sildenafil solution, sildenafil-containing polymer formulations showed a prolonged in-vitro drug release profile. Likewise, 17 and 21 wt.% of poloxamer 407 were characterized by a sustained sildenafil transfer from the lung into the perfusate. However, a 10 wt.% polymer solution displayed an immediate sildenafil absorption. Interestingly, increasing the poloxamer 407 concentration (21 and 17 vs. 10 wt.%) led to decreased organ weight gain kinetics and a lower total protein content found in the bronchoalveolar lavage fluid. CONCLUSIONS: In-situ forming controlled release hydrogels represent a viable approach for inhalative therapy.


Assuntos
Sistemas de Liberação de Medicamentos , Pulmão/metabolismo , Poloxâmero/química , Citrato de Sildenafila/administração & dosagem , Animais , Química Farmacêutica , Preparações de Ação Retardada , Portadores de Fármacos/química , Liberação Controlada de Fármacos , Hidrogéis , Cinética , Coelhos , Reologia , Citrato de Sildenafila/farmacocinética , Temperatura de Transição , Vasodilatadores/administração & dosagem , Vasodilatadores/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...